Abstract: Recent developments in Adoptive Immunotherapy for cancer management
have lead clinicians to employ these techniques in hospital settings. Much data has been
produced that indicates the effectiveness of introducing enhanced and expanded immune
systems into cancer hosts. In this retrospective study we take another look at the
Kirschner mathematical model for immune-tumor interactions in light of data presented
by Rosenburg on patients with Metastatic Melanoma or Renal Cell Cancer.